SECOND AMENDMENT TO SUBLEASESublease • August 12th, 2024 • CARGO Therapeutics, Inc. • Biological products, (no disgnostic substances)
THIS SECOND AMENDMENT TO SUBLEASE (this “Amendment”) is made as of June 21, 2024 by and between BigHat Biosciences, Inc., a Delaware corporation (“Sublessor”) and Cargo Therapeutics, Inc. (formerly known as Syncopation Life Sciences, Inc.), a Delaware corporation (“Sublessee”), with reference to the following facts and objectives:
